Molecular Pathology

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dasgupta, S
Right arrow Articles by Panda, C K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dasgupta, S
Right arrow Articles by Panda, C K
Molecular Pathology 2003;56:263-269
© 2003 BMJ Publishing Group Ltd. & Association of Clinical Pathologists


ORIGINAL ARTICLE

Differential deletions of chromosome 3p are associated with the development of uterine cervical carcinoma in Indian patients

S Dasgupta1, S B Chakraborty1, A Roy2, S Roychowdhury3 and C K Panda1

1 Department of Oncogene Regulation, Chittaranjan National Cancer Institute, 37, S. P.Mukherjee Road, Calcutta: 700026, India
2 Department of Pathology, Bankura Sammilani Medical College, Bankura, West Bengal, India
3 Department of Human Genetics, Indian Institute of Chemical Biology, 4, Raja S. C. Mullick Road, Calcutta-700032, India

Correspondence to:
Dr C K Panda, Department of Oncogene Regulation, Chittaranjan National Cancer Institute, 37, S.P. Mukherjee Road, Calcutta-700026, India;
ckpanda{at}vsnl.net

Background: Deletions in chromosome 3 occur frequently in uterine cervical carcinoma (CA-CX). The common consensus regions deleted during CA-CX development are not well defined, and have not been correlated with tumour progression.

Aims: To define specific regions of chromosome 3 deleted during development of CA-CX and to correlate these with clinicopathological data.

Methods: Deletion mapping of chromosome 3 was done in seven cervical intraepithelial neoplasia (CIN) and 43 primary CA-CX samples using 20 highly polymorphic microsatellite markers.

Results: Deletions of chromosome 3 were significantly associated with tumour progression. High frequencies (33–53%) of loss of heterozygosity (LOH) were found in 3p26.1, 3p22.3, 3p21.2, and 3p13, suggesting the location of putative tumour suppressor genes (TSGs) in these regions. Among these four regions, deletions in 3p21.2 were suggested to occur early during CA-CX development. A significant correlation was found between LOH at 3p26.1 and 3p22.3 with tumour progression from stage I/IIB to stage III/IV. No association was found with the highly deleted regions and human papillomavirus positivity, parity, or menopausal status. Microsatellite size alteration was seen in only seven of the samples. However, rare biallelic alterations were seen in and around the highly deleted regions. Loss of normal copy of chromosome 3 and interstitial alterations in chromosome 3p were seen in some samples.

Conclusion: These four regions on chromosome 3p may be differentially deleted during specific stages of CA-CX development. The putative TSGs located in these regions may have a cumulative effect on tumour progression.


Keywords: squamous cell carcinoma of the uterine cervix; chromosome 3 alterations; tumour suppressor gene(s); human papilloma virus infection

Abbreviations: CA-CX, uterine cervical carcinoma; CIN, cervical intraepithelial neoplasia; FAL, fractional allele loss; HPV, human papillomavirus; LOH, loss of heterozygosity; MA, microsatellite size alteration; PCR, polymerase chain reaction; RCC, renal cell carcinoma; RFLP, restriction fragment length polymorphism; TSG, tumour suppressor gene




This article has been cited by other articles:


Home page
Cancer Res.Home page
M. P. Hitchins, V. A. Lin, A. Buckle, K. Cheong, N. Halani, S. Ku, C.-T. Kwok, D. Packham, C. M. Suter, A. Meagher, et al.
Epigenetic Inactivation of a Cluster of Genes Flanking MLH1 in Microsatellite-Unstable Colorectal Cancer
Cancer Res., October 1, 2007; 67(19): 9107 - 9116.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
S Mitra, S Banerjee, C Misra, R K Singh, A Roy, A Sengupta, C K Panda, and S Roychoudhury
Interplay between human papilloma virus infection and p53 gene alterations in head and neck squamous cell carcinoma of an Indian patient population
J. Clin. Pathol., September 1, 2007; 60(9): 1040 - 1047.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
S Mitra, C Misra, R K Singh, C K Panda, and S Roychoudhury
Association of specific genotype and haplotype of p53 gene with cervical cancer in India
J. Clin. Pathol., January 1, 2005; 58(1): 26 - 31.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Molecular Pathology Journal of Clinical Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.